CCP Score Articles

The CCP test is a validated molecular assay that assesses prostate cancer-specific disease progression and mortality risk when combined with clinicopathologic parameters.

PURPOSE - To identify prognostic biomarkers in prostate cancer (PCa) by means of a radio-genomics strategy that integrates gene expression (CCP score) and medical images.

To compare the prognostic capabilities and clinical utility of the cell cycle progression (CCP) gene expression classifier test, multiparametric magnetic resonance imaging (mpMRI) with Prostate Imaging Reporting and Data System (PI-RADS) scoring, and clinicopathologic data in select prostate cancer (PCa) medical management scenarios.